FDA Official Gives Policy Update On Lab-Developed Tests
Most laboratory-developed tests have no regulatory predicates, said FDA's Elizabeth Mansfield, hinting that many may require pre-market submissions that go beyond FDA's 510(k) review standards once the agency initiates plans for active oversight of the category.
You may also be interested in...
Industry is anxiously awaiting guidance from FDA on the development of companion diagnostics for drugs that will inform efforts to move towards personalized medicine.
The US Medicare agency introduced a new end-stage renal disease treatment model on Friday to incentivize use of home dialysis.